An overview of the functions and mechanisms of APOBEC3A in tumorigenesis

Area of Science:

• Immunology
• Genetics
• Oncology

Background:

• The APOBEC3 (A3) gene family is vital for innate immunity, involved in DNA/RNA single-strand deamination.
• Aberrant expression of A3A is increasingly recognized as a significant contributor to tumor-associated mutations and tumorigenesis.
• A3A's role in editing viral genomes contrasts with its potential to induce chronic mutations in host genomes.

Purpose of the Study:

• To comprehensively review and categorize the evidence linking A3A to cancer development.
• To elucidate the underlying mechanisms through which A3A influences tumorigenesis.
• To highlight A3A's potential as a therapeutic target in cancer treatment.

Main Methods:

• Literature review and synthesis of existing research on A3A and cancer.
• Classification of studies based on proposed mechanisms of A3A-driven tumorigenesis.
• Analysis of A3A expression patterns in various cancer types and immune cells.

Main Results:

• A3A acts as a key driver gene in cancer-related mutations, contributing to somatic cell mutations.
• Abnormal A3A expression in tumor cells can directly impact proliferation and migration.
• A3A expression in macrophages influences tumor-infiltrating immune cells and tumor growth.

Conclusions:

• A3A is closely implicated in the development of diverse cancers.
• Targeting A3A presents a promising avenue for novel cancer therapies.
• Further research into A3A's functions is crucial for advancing cancer treatment strategies.